Showing results (171-180 of 209) with videos related to
Sort By:
Pageof 21
Digestive Diseases and Sciences|September 30, 1998
Molecular analysis of suppression of interleukin-8 production by rebamipide in Helicobacter pylori-stimulated gastric cancer cell linesM Aihara, A Azuma, H Takizawa, et al.Investigational New Drugs|October 28, 2003
Immunomodulatory effects of docetaxel on human lymphocytesMing-Sing Si, David K Imagawa, Ping Ji, et al.Annals of Surgery|January 9, 2013
Surgery for gallstone ileus: a nationwide comparison of trends and outcomesWissam J Halabi, Celeste Y Kang, Noor Ketana, et al.Transplantation|January 1, 1991
The role of tumor necrosis factor in allograft rejection. III. Evidence that anti-TNF antibody therapy prolongs allograft survival in rats with acute rejectionD K Imagawa, J M Millis, P Seu, et al.Journal of Hepatocellular Carcinoma|May 27, 2021
Phase I Trial on Arterial Embolization with Hypoxia Activated Tirapazamine for Unresectable Hepatocellular CarcinomaNadine Abi-Jaoudeh, Farshid Dayyani, Pei Jer Chen, et al.Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|November 18, 2010
Adenosquamous versus adenocarcinoma of the pancreas: a population-based outcomes analysisMatthew Harold G Katz, Thomas H Taylor, Waddah B Al-Refaie, et al.World Journal of Surgery|May 27, 2016
Global Estimation of Surgical Procedures Needed for Forcibly Displaced PersonsYuanting Zha, Barclay Stewart, Eugenia Lee, et al.Clinical Transplants|January 1, 1991
Liver transplantation at UCLA: report of clinical activitiesD K Imagawa, S M Strange, A Shaked, et al.HPB : the Official Journal of the International Hepato Pancreato Biliary Association|May 2, 2019
Perioperative blood transfusion is associated with an increased risk for post-surgical infection following pancreaticoduodenectomyAustin R Dosch, Areg Grigorian, Patrick T Delaplain, et al.Transplantation|September 27, 1995
Lack of correlation between the magnitude of preservation injury and the incidence of acute rejection, need for OKT3, and conversion to FK506 in cyclosporine-treated primary liver allograft recipientsC R Shackleton, P Martin, J Melinek, et al.Pageof 21